Continuous MYD88 Activation Is Associated With Expansion and Then Transformation of IgM Differentiating Plasma Cells.

Amino Acid Substitution Animals Cell Differentiation / genetics Humans Immunoglobulin M / genetics Lymphoma, Large B-Cell, Diffuse / genetics Mice Mice, Transgenic Mutation, Missense Myeloid Differentiation Factor 88 / genetics Neoplasm Proteins / genetics Plasma Cells / immunology
B-cell lymphoma IgM secretion MYD88 L265P mutation lymphoplasmacytic lymphoma/Waldenstrom’s macroglobulinemia monoclonal Ig peak plasma cell

Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2021
Historique:
received: 14 12 2020
accepted: 14 04 2021
entrez: 21 5 2021
pubmed: 22 5 2021
medline: 23 9 2021
Statut: epublish

Résumé

Activating mutations of

Identifiants

DOI: 10.3389/fimmu.2021.641692 PMID: 34017329 PMC: PMC8129569
pubmed: 34017329
doi: 10.3389/fimmu.2021.641692
pmc: PMC8129569
doi:

Substances chimiques

Immunoglobulin M 0
Myd88 protein, mouse 0
Myeloid Differentiation Factor 88 0
Neoplasm Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

641692

Informations de copyright

Copyright © 2021 Ouk, Roland, Gachard, Poulain, Oblet, Rizzo, Saintamand, Lemasson, Carrion, Thomas, Balabanian, Espéli, Parrens, Soubeyran, Boulin, Faumont, Feuillard and Vincent-Fabert.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

J Virol. 2009 May;83(10):5014-27
pubmed: 19264782
Curr Oncol Rep. 2019 Feb 26;21(3):27
pubmed: 30806816
Cell Commun Signal. 2019 Aug 5;17(1):89
pubmed: 31382969
Blood. 2016 Aug 11;128(6):827-38
pubmed: 27301862
J Bone Metab. 2014 Feb;21(1):55-60
pubmed: 24707467
Nucleic Acids Res. 1995 Sep 11;23(17):3539-46
pubmed: 7567467
Proc Natl Acad Sci U S A. 1992 Jul 15;89(14):6232-6
pubmed: 1631115
Blood. 2021 May 20;137(20):2785-2799
pubmed: 33232972
Nat Immunol. 2007 Jul;8(7):665-8
pubmed: 17579640
Mod Pathol. 2017 Oct;30(10):1338-1366
pubmed: 28664939
Leukemia. 2013 Aug;27(8):1722-8
pubmed: 23446312
Leukemia. 2014 Apr;28(4):871-9
pubmed: 24056880
Cancer Med. 2018 Jun;7(6):2621-2628
pubmed: 29745034
Proc Natl Acad Sci U S A. 2009 Mar 10;106(10):3895-900
pubmed: 19228948
Blood. 2005 Jan 15;105(2):474-80
pubmed: 15345598
Leukemia. 2011 Apr;25(4):681-8
pubmed: 21233831
Haematologica. 2009 Mar;94(3):355-63
pubmed: 19211641
Front Immunol. 2020 Dec 01;11:602868
pubmed: 33343574
Clin Cancer Res. 2016 Mar 15;22(6):1480-8
pubmed: 26490317
Blood. 2010 Sep 16;116(11):1895-8
pubmed: 20538806
Blood. 2017 Oct 5;130(14):1644-1648
pubmed: 28801450
Bioinformatics. 2011 Nov 1;27(21):2957-63
pubmed: 21903629
Haematologica. 2017 May;102(5):883-894
pubmed: 28232371
Transl Lung Cancer Res. 2019 Dec;8(6):1000-1015
pubmed: 32010578
Proc Natl Acad Sci U S A. 2003 Aug 19;100(17):9991-6
pubmed: 12900505
Cell Tissue Res. 2019 Jun;376(3):413-423
pubmed: 30707290
Haematologica. 2019 Dec;104(12):2337-2348
pubmed: 31699794
Nature. 2011 Feb 3;470(7332):115-9
pubmed: 21179087
N Engl J Med. 2012 Aug 30;367(9):826-33
pubmed: 22931316
J Exp Med. 2014 Mar 10;211(3):413-26
pubmed: 24534189
Am Soc Clin Oncol Educ Book. 2018 May 23;38:675-680
pubmed: 30231368
Cell Mol Immunol. 2019 Apr;16(4):412-414
pubmed: 30635651
Nat Commun. 2016 Aug 16;7:12687
pubmed: 27527920
Blood. 2009 Nov 5;114(19):4158-68
pubmed: 19696203
Nucleic Acids Res. 1997 Mar 15;25(6):1317-8
pubmed: 9092650
Cell Mol Immunol. 2019 Jun;16(6):621-624
pubmed: 30967638
J Pathol Inform. 2012;3:25
pubmed: 22934238
Nat Genet. 1999 Jan;21(1):70-1
pubmed: 9916792
Mod Pathol. 2006 Jul;19(7):891-8
pubmed: 16636680
J Neurooncol. 2018 Feb;136(3):495-503
pubmed: 29168084
Nat Rev Immunol. 2009 Nov;9(11):767-77
pubmed: 19855403
Leukemia. 2013 Jan;27(1):183-9
pubmed: 22944768
Blood Adv. 2018 Aug 14;2(15):1985-1997
pubmed: 30104397
Blood. 2016 Sep 8;128(10):1321-8
pubmed: 27432877
J Exp Med. 2008 Jun 9;205(6):1317-29
pubmed: 18490492
Leukemia. 2012 May;26(5):1122-7
pubmed: 22033491
Curr Biol. 2002 Mar 19;12(6):467-71
pubmed: 11909531
Blood Adv. 2019 Nov 12;3(21):3360-3374
pubmed: 31698464
Crit Care Med. 2006 Sep;34(9):2377-85
pubmed: 16850005
Blood. 2020 Aug 6;136(6):684-697
pubmed: 32325488
J Clin Invest. 1972 Mar;51(3):701-5
pubmed: 4622108
Blood. 2016 Jun 2;127(22):2732-41
pubmed: 27048211
J Exp Med. 2014 Sep 22;211(10):2103-18
pubmed: 25180063
Hematology Am Soc Hematol Educ Program. 2012;2012:586-94
pubmed: 23233639
J Biol Chem. 2020 May 1;295(18):6236-6248
pubmed: 32179652

Auteurs

Catherine Ouk (C)

UMR CNRS 7276/INSERM U1262 CRIBL, University of Limoges, and Hematology Laboratory of Dupuytren Hospital University Center (CHU) of Limoges, Limoges, France.

Lilian Roland (L)

UMR CNRS 7276/INSERM U1262 CRIBL, University of Limoges, and Hematology Laboratory of Dupuytren Hospital University Center (CHU) of Limoges, Limoges, France.

Nathalie Gachard (N)

UMR CNRS 7276/INSERM U1262 CRIBL, University of Limoges, and Hematology Laboratory of Dupuytren Hospital University Center (CHU) of Limoges, Limoges, France.

Stéphanie Poulain (S)

UMR CANTHER « CANcer Heterogeneity, Plasticity and Resistance to THERapies » INSERM 1277-CNRS 9020 UMRS 12, University of Lille, Hematology Laboratory, Biology and Pathology Center, CHU de Lille, Lille, France.

Christelle Oblet (C)

UMR CNRS 7276/INSERM U1262 CRIBL, University of Limoges, and Hematology Laboratory of Dupuytren Hospital University Center (CHU) of Limoges, Limoges, France.

David Rizzo (D)

UMR CNRS 7276/INSERM U1262 CRIBL, University of Limoges, and Hematology Laboratory of Dupuytren Hospital University Center (CHU) of Limoges, Limoges, France.

Alexis Saintamand (A)

UMR CNRS 7276/INSERM U1262 CRIBL, University of Limoges, and Hematology Laboratory of Dupuytren Hospital University Center (CHU) of Limoges, Limoges, France.

Quentin Lemasson (Q)

UMR CNRS 7276/INSERM U1262 CRIBL, University of Limoges, and Hematology Laboratory of Dupuytren Hospital University Center (CHU) of Limoges, Limoges, France.

Claire Carrion (C)

UMR CNRS 7276/INSERM U1262 CRIBL, University of Limoges, and Hematology Laboratory of Dupuytren Hospital University Center (CHU) of Limoges, Limoges, France.

Morgane Thomas (M)

UMR CNRS 7276/INSERM U1262 CRIBL, University of Limoges, and Hematology Laboratory of Dupuytren Hospital University Center (CHU) of Limoges, Limoges, France.

Karl Balabanian (K)

Institut de Recherche Saint-Louis, EMiLy, INSERM U1160, University of Paris, Paris, France.

Marion Espéli (M)

Institut de Recherche Saint-Louis, EMiLy, INSERM U1160, University of Paris, Paris, France.

Marie Parrens (M)

Pathology Department, Hospital University Center of Bordeaux, Bordeaux, France.

Isabelle Soubeyran (I)

Laboratory of Pathology, Institut Bergonié, Bordeaux, France.

Mélanie Boulin (M)

UMR CNRS 7276/INSERM U1262 CRIBL, University of Limoges, and Hematology Laboratory of Dupuytren Hospital University Center (CHU) of Limoges, Limoges, France.

Nathalie Faumont (N)

UMR CNRS 7276/INSERM U1262 CRIBL, University of Limoges, and Hematology Laboratory of Dupuytren Hospital University Center (CHU) of Limoges, Limoges, France.

Jean Feuillard (J)

UMR CNRS 7276/INSERM U1262 CRIBL, University of Limoges, and Hematology Laboratory of Dupuytren Hospital University Center (CHU) of Limoges, Limoges, France.

Christelle Vincent-Fabert (C)

UMR CNRS 7276/INSERM U1262 CRIBL, University of Limoges, and Hematology Laboratory of Dupuytren Hospital University Center (CHU) of Limoges, Limoges, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Phénomènes génétiques › Mutagenèse › Substitution d'acide aminé › Continuous MYD88 Activation Is Associated With...
questionsmedicales.fr › Eucaryotes › Animaux › Continuous MYD88 Activation Is Associated With...
questionsmedicales.fr › Phénomènes physiologiques cellulaires › Différenciation cellulaire › Continuous MYD88 Activation Is Associated With...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Continuous MYD88 Activation Is Associated With...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Globulines › Sérum-globulines › Immunoglobulines › Anticorps › Isotypes des immunoglobulines › Immunoglobuline M › Continuous MYD88 Activation Is Associated With...
questionsmedicales.fr › Maladies du système immunitaire › Syndromes immunoprolifératifs › Syndromes lymphoprolifératifs › Lymphomes › Lymphome malin non hodgkinien › Lymphome B › Lymphome B diffus à grandes cellules › Continuous MYD88 Activation Is Associated With...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Rodentia › Muridae › Murinae › Souris › Continuous MYD88 Activation Is Associated With...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Rodentia › Muridae › Murinae › Souris › Souris transgéniques › Continuous MYD88 Activation Is Associated With...
questionsmedicales.fr › Phénomènes génétiques › Variation génétique › Mutation › Mutation faux-sens › Continuous MYD88 Activation Is Associated With...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines et peptides de signalisation intracellulaire › Protéines adaptatrices de la transduction du signal › Facteur de différenciation myéloïde-88 › Continuous MYD88 Activation Is Associated With...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines tumorales › Continuous MYD88 Activation Is Associated With...
questionsmedicales.fr › Systèmes sanguin et immunitaire › Système immunitaire › Leucocytes › Agranulocytes › Lymphocytes › Lymphocytes B › Plasmocytes › Continuous MYD88 Activation Is Associated With...